News Releases

Sep 08, 2020
SHANGHAI and GAITHERSBURG, Md. , Sept. 8, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in
Displaying 1 - 10 of 33